Skip to main content
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.80
-0.29 (-4.09%)
At close: Apr 28, 2026, 4:00 PM EDT
6.85
+0.05 (0.74%)
After-hours: Apr 28, 2026, 6:05 PM EDT

Cartesian Therapeutics Revenue

In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%. Cartesian Therapeutics had revenue of $947.00K in the quarter ending December 31, 2025, a decrease of -224.77%.

Revenue (ttm)
$2.80M
Revenue Growth
-92.81%
P/S Ratio
64.45
Revenue / Employee
$37,293
Employees
75
Market Cap
180.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 149.50M
Protalix BioTherapeutics 52.74M
Precision BioSciences 34.26M
Tonix Pharmaceuticals Holding 13.11M
Korro Bio 6.39M
Humacyte 2.04M
Revenue Rankings

RNAC News

More News